Tuesday, February 05, 2013

First Circuit -- Silverstrand Investments v. Amag Pharmaceuticals, Inc.

Securities -- to survive motion to dismiss, Section 503 claim, there must be a known risk factor impacting present or future interests.  And there was.

Silverstrand Investments v. Amag Pharmaceuticals, Inc. 
Compiled by D.E. Frydrychowski, who is, not incidentally, not giving you legal advice.

Category tags above are sporadically maintained Do not rely. Do not rely. Do not rely.

Author's SSRN page here.